Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging.

Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G.

Neurology. 1993 Mar;43(3 Pt 1):509-15.

PMID:
8450992
[PubMed - indexed for MEDLINE]
2.

N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals.

Meyerhoff DJ, MacKay S, Poole N, Dillon WP, Weiner MW, Fein G.

Magn Reson Imaging. 1994;12(4):653-9.

PMID:
8057770
[PubMed - indexed for MEDLINE]
3.

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.

Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G.

Neurology. 1999 Mar 23;52(5):995-1003.

PMID:
10102419
[PubMed - indexed for MEDLINE]
4.

Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.

Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW.

Ann Neurol. 1994 Jul;36(1):40-7.

PMID:
8024260
[PubMed - indexed for MEDLINE]
5.

Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.

Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.

Ann Neurol. 1994 Aug;36(2):157-65.

PMID:
8053651
[PubMed - indexed for MEDLINE]
6.

Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?

Mendes-Ribeiro JA, Soares R, Simões-Ribeiro F, Guimarães ML.

J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):518-22.

PMID:
9771777
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.

Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ.

Invest Radiol. 1997 Aug;32(8):485-95.

PMID:
9258737
[PubMed - indexed for MEDLINE]
8.

Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study.

Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, González RG.

Neurology. 1996 Mar;46(3):783-8. Erratum in: Neurology 1996 Jun;46(6):1787.

PMID:
8618683
[PubMed - indexed for MEDLINE]
9.

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A.

Arch Gen Psychiatry. 1998 Apr;55(4):346-52.

PMID:
9554430
[PubMed - indexed for MEDLINE]
10.

Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.

Simone IL, Tortorella C, Federico F, Liguori M, Lucivero V, Giannini P, Carrara D, Bellacosa A, Livrea P.

J Neurol Sci. 2001 Jan 1;182(2):143-50.

PMID:
11137520
[PubMed - indexed for MEDLINE]
11.

Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.

Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J.

J Clin Psychiatry. 2003 Mar;64(3):235-42.

PMID:
12716263
[PubMed - indexed for MEDLINE]
12.

Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis.

Nelson JA, Dou H, Ellison B, Uberti M, Xiong H, Anderson E, Mellon M, Gelbard HA, Boska M, Gendelman HE.

J Neurosci Res. 2005 May 15;80(4):562-75.

PMID:
15825192
[PubMed - indexed for MEDLINE]
13.

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA; HIV MRS Consortium.

Neuroimage. 2004 Dec;23(4):1336-47.

PMID:
15589098
[PubMed - indexed for MEDLINE]
14.

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.

Psychiatry Res. 2004 Jul 30;131(2):95-105.

PMID:
15313516
[PubMed - indexed for MEDLINE]
15.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
[PubMed - indexed for MEDLINE]
16.

Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.

Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D.

AJNR Am J Neuroradiol. 2001 Jan;22(1):119-27.

PMID:
11158897
[PubMed - indexed for MEDLINE]
Free Article
17.

Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.

Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW.

Neurology. 1998 Jun;50(6):1800-5.

PMID:
9633731
[PubMed - indexed for MEDLINE]
18.

Localized cerebral proton MR spectroscopy in HIV infection and AIDS.

Chong WK, Paley M, Wilkinson ID, Hall-Craggs MA, Sweeney B, Harrison MJ, Miller RF, Kendall BE.

AJNR Am J Neuroradiol. 1994 Jan;15(1):21-5.

PMID:
8141061
[PubMed - indexed for MEDLINE]
19.

Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy.

Gabis L, Belman A, Huang W, Milazzo M, Nachman S.

J Child Neurol. 2006 Jun;21(6):486-90.

PMID:
16948932
[PubMed - indexed for MEDLINE]
20.

Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.

Chang L, Ernst T, Speck O, Grob CS.

Am J Psychiatry. 2005 Feb;162(2):361-9.

PMID:
15677602
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk